SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 3rd, 2018 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of November 26, 2018, between Generex Biotechnology Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”).
STOCK PLEDGE AGREEMENTStock Pledge Agreement • December 3rd, 2018 • Generex Biotechnology Corp • Pharmaceutical preparations • New York
THIS STOCK PLEDGE AGREEMENT (this “Agreement”), dated as of November 26, 2018, by and between Joseph Moscato (“Pledgor”) and Istvan Elek (“Pledgee”);
NOTE DUE November 26, 2019Generex Biotechnology Corp • December 3rd, 2018 • Pharmaceutical preparations • New York
THIS NOTE is one of a series of duly authorized and validly issued Notes of Generex Biotechnology Corporation, a Delaware corporation, (the “Borrower”), having a place of business at 10102 USA Today Way, Miramar, Florida 33025, email: josephmoscatojr@gmail.com, due November 26, 2019 (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
